持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/06 | 3,330 | 3,330 | 3,290 | 3,290 | -15 | -0.5% | 18,600 |
| 2024/09/05 | 3,270 | 3,310 | 3,265 | 3,305 | +15 | +0.5% | 19,200 |
| 2024/09/04 | 3,280 | 3,335 | 3,265 | 3,290 | -45 | -1.3% | 19,600 |
| 2024/09/03 | 3,285 | 3,375 | 3,285 | 3,335 | +55 | +1.7% | 18,200 |
| 2024/09/02 | 3,300 | 3,320 | 3,240 | 3,280 | -20 | -0.6% | 13,900 |
| 2024/08/30 | 3,320 | 3,335 | 3,300 | 3,300 | +15 | +0.5% | 20,900 |
| 2024/08/29 | 3,320 | 3,340 | 3,280 | 3,285 | -55 | -1.6% | 10,500 |
| 2024/08/28 | 3,310 | 3,345 | 3,290 | 3,340 | +10 | +0.3% | 8,500 |
| 2024/08/27 | 3,310 | 3,355 | 3,310 | 3,330 | +15 | +0.5% | 10,600 |
| 2024/08/26 | 3,320 | 3,320 | 3,250 | 3,315 | +30 | +0.9% | 18,300 |
| 2024/08/23 | 3,280 | 3,320 | 3,275 | 3,285 | +5 | +0.2% | 10,600 |
| 2024/08/22 | 3,230 | 3,280 | 3,230 | 3,280 | +50 | +1.5% | 8,200 |
| 2024/08/21 | 3,255 | 3,280 | 3,220 | 3,230 | -70 | -2.1% | 9,600 |
| 2024/08/20 | 3,255 | 3,300 | 3,245 | 3,300 | +60 | +1.9% | 11,900 |
| 2024/08/19 | 3,255 | 3,290 | 3,215 | 3,240 | -50 | -1.5% | 35,100 |
| 2024/08/16 | 3,290 | 3,295 | 3,235 | 3,290 | +55 | +1.7% | 17,000 |
| 2024/08/15 | 3,260 | 3,260 | 3,225 | 3,235 | -20 | -0.6% | 16,000 |
| 2024/08/14 | 3,245 | 3,260 | 3,185 | 3,255 | +10 | +0.3% | 13,100 |
| 2024/08/13 | 3,125 | 3,285 | 3,125 | 3,245 | +50 | +1.6% | 17,500 |
| 2024/08/09 | 3,260 | 3,280 | 3,155 | 3,195 | +5 | +0.2% | 49,700 |
| 2024/08/08 | 3,165 | 3,250 | 3,085 | 3,190 | +5 | +0.2% | 26,800 |
| 2024/08/07 | 3,075 | 3,250 | 3,060 | 3,185 | +80 | +2.6% | 29,800 |
| 2024/08/06 | 3,245 | 3,245 | 3,030 | 3,105 | +70 | +2.3% | 50,700 |
| 2024/08/05 | 3,085 | 3,225 | 2,961 | 3,035 | -180 | -5.6% | 50,900 |
| 2024/08/02 | 3,310 | 3,335 | 3,135 | 3,215 | -265 | -7.6% | 84,900 |
| 2024/08/01 | 3,540 | 3,540 | 3,420 | 3,480 | -60 | -1.7% | 29,300 |
| 2024/07/31 | 3,415 | 3,540 | 3,415 | 3,540 | +80 | +2.3% | 34,300 |
| 2024/07/30 | 3,515 | 3,525 | 3,455 | 3,460 | -40 | -1.1% | 27,500 |
| 2024/07/29 | 3,485 | 3,520 | 3,440 | 3,500 | +15 | +0.4% | 33,300 |
| 2024/07/26 | 3,495 | 3,545 | 3,485 | 3,485 | +25 | +0.7% | 47,000 |
| 2024/07/25 | 3,380 | 3,480 | 3,380 | 3,460 | +35 | +1% | 41,900 |
| 2024/07/24 | 3,400 | 3,455 | 3,400 | 3,425 | -15 | -0.4% | 17,100 |
| 2024/07/23 | 3,385 | 3,460 | 3,385 | 3,440 | +55 | +1.6% | 26,100 |
| 2024/07/22 | 3,425 | 3,425 | 3,375 | 3,385 | -75 | -2.2% | 26,500 |
| 2024/07/19 | 3,465 | 3,485 | 3,420 | 3,460 | -5 | -0.1% | 20,100 |
| 2024/07/18 | 3,405 | 3,515 | 3,375 | 3,465 | +35 | +1% | 38,600 |
| 2024/07/17 | 3,375 | 3,430 | 3,375 | 3,430 | +65 | +1.9% | 28,600 |
| 2024/07/16 | 3,370 | 3,420 | 3,345 | 3,365 | -5 | -0.1% | 61,400 |
| 2024/07/12 | 3,305 | 3,370 | 3,305 | 3,370 | +45 | +1.4% | 32,600 |
| 2024/07/11 | 3,330 | 3,345 | 3,305 | 3,325 | +25 | +0.8% | 35,100 |
| 2024/07/10 | 3,330 | 3,330 | 3,280 | 3,300 | -50 | -1.5% | 52,200 |
| 2024/07/09 | 3,295 | 3,370 | 3,295 | 3,350 | +60 | +1.8% | 44,500 |
| 2024/07/08 | 3,300 | 3,330 | 3,280 | 3,290 | ±0 | ±0% | 38,700 |
| 2024/07/05 | 3,285 | 3,330 | 3,285 | 3,290 | +5 | +0.2% | 30,100 |
| 2024/07/04 | 3,285 | 3,305 | 3,240 | 3,285 | +30 | +0.9% | 35,200 |
| 2024/07/03 | 3,195 | 3,260 | 3,195 | 3,255 | +40 | +1.2% | 38,700 |
| 2024/07/02 | 3,150 | 3,235 | 3,150 | 3,215 | +65 | +2.1% | 59,400 |
| 2024/07/01 | 3,110 | 3,155 | 3,110 | 3,150 | +35 | +1.1% | 27,600 |
| 2024/06/28 | 3,080 | 3,115 | 3,080 | 3,115 | +15 | +0.5% | 25,000 |
| 2024/06/27 | 3,115 | 3,120 | 3,080 | 3,100 | -30 | -1% | 36,500 |
51～
100
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 332,000円 | +3.0% | +27.5% | 2.41% | 21.02倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.23倍 | 3.88倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 466,500円 | +12.0% | +28.1% | 2.57% | 25.71倍 | 1.09倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 222,100円 | +13.6% | +29.2% | 2.07% | 11.52倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.47倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
